行情

BNTC

BNTC

Benitec
NASDAQ

实时行情|Nasdaq Last Sale

0.6450
+0.0235
+3.78%
已收盘, 16:00 11/12 EST
开盘
0.6400
昨收
0.6215
最高
0.6600
最低
0.6400
成交量
3.50万
成交额
--
52周最高
2.650
52周最低
0.5000
市值
828.92万
市盈率(TTM)
2.911
分时
5日
1月
3月
1年
5年

BNTC 新闻

  • 沪指低开震荡 纳指再创新高、期金连跌四日
  • 新浪财经.2小时前
  • 马化腾的科技之战
  • 创事记.3小时前
  • 谷歌回应数据滥用质疑:未将个人医疗数据用于AI研究
  • 新浪科技.3小时前
  • IEA:全球石油需求增长将从2025年起放缓
  • 环球外汇网官网.3小时前

更多

所属板块

生物技术和医学研究
+0.45%
制药与医学研究
+0.31%

热门股票

名称
价格
涨跌幅

BNTC 简况

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology.
展开

Webull提供Benitec Biopharma Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。